Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Xi Jinping to test limits of friendship with Vladimir Putin on Russia state visit
    • South African military deployed to prevent planned national shutdown
    • Xi Jinping praises Vladimir Putin’s ‘strong leadership’ in Kremlin talks
    • Xi Jinping-Vladimir Putin talks highlight Russia’s role as ‘junior partner’ to China
    • Two companies, one trade: the switch that keeps Putin’s oil flowing
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Banks in turmoil
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • Wall Street CEOs seek new plan for First Republic
      • Tens of thousands of jobs at risk after UBS takeover of Credit Suisse
      • Swiss under fire for shotgun marriage of Credit Suisse and UBS
      • Rupert Murdoch engaged to be married for fifth time
      • ‘Credit Suisse is part of our history’: shocked nation digests bank’s collapse
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Banks and markets updates from March 20: S&P cuts UBS’s outlook, Credit Suisse warns of possible job cuts
      • Credit Suisse bondholders in uproar over $17bn debt wipeout
      • Holders of $17bn of Credit Suisse bonds wiped out under UBS takeover
      • US bank stocks rise as investors assess efforts to calm turmoil
      • Additional tier 1 bonds: the wiped-out debt at centre of Credit Suisse takeover
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • The real meaning of Xi’s visit to Putin
      • There are several reasons to worry about the health of Europe’s banks
      • Why I never invest in bank shares
      • Four ways to fix the bank problem
      • Banking turmoil intensifies the need for better Federal Reserve policymaking
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • From SVB to the BBC: why did no one see the crisis coming?
      • Football’s first female super-agent Rafaela Pimenta on dealmaking and discrimination
      • Social media content moderators lead charge for better rights
      • Patrick Vieira on making the switch to management: ‘It’s much easier to play football’
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • Meet the watch influencers
      • Resident Evil 4 Remake review — lavish improvement on the action-horror classic
      • Five great Greek boltholes to book 
      • Assistive tech to put you in complete control
      • Michael Heseltine: ‘The adults are back in charge’
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Genomics

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Monday, 13 March, 2023
      Illumina Inc
      Carl Icahn takes aim at genome sequencer Illumina over Grail deal

      Company’s shares jump after activist investor launches proxy battle

    • Wednesday, 8 March, 2023
      Cost of gene treatments for once incurable diseases too high, scientists warn

      Therapies based on editing of human genomes predicted to have a price tag of $2mn per patient

    • Wednesday, 8 March, 2023
      UK politics & policy
      Chinese genomics company accused of hack attempts by UK minister

      Government later says no ‘evidence’ of attempted hacking of NHS genetic data centre by BGI

    • Tuesday, 7 March, 2023
      Anjana Ahuja
      We need rules before we let the genome-editing genie out of the bottle

      Changing human DNA brings hope for treating diseases but raises concerns such as equitable access

    • Monday, 6 March, 2023
      Chris Miller
      There’s a new US national security obsession — biotech

      The ability to apply massive computing power to DNA is causing concern over biological warfare

    • Tuesday, 31 January, 2023
      Anjana Ahuja
      Dead as a dodo? The unsettling bid to bring back extinct species

      We should focus on conserving endangered animals rather than resurrecting those already gone

    • Sunday, 29 January, 2023
      News in-depthIllumina Inc
      Has Illumina taken the wrong path in its Grail quest?

      DNA sequencing expert’s investors question acquisition of cancer testing group that has also angered EU regulators

    • Friday, 6 January, 2023
      Medical science
      UK signs deal with BioNTech for cutting-edge cancer trials

      Covid-19 vaccine maker hails ‘huge’ investment aimed at recruiting 10,000 participants with NHS

    • Friday, 30 December, 2022
      UK to embark on groundbreaking new genomics projects

      Programmes involving millions of volunteers will cement Britain’s place as leader in DNA research

    • Tuesday, 13 December, 2022
      100,000 newborn babies set to have their DNA fully decoded

      Genomics England programme aims to extend the number of treatable conditions detected to about 200

    • Thursday, 10 November, 2022
      The Big Read
      Mood shifts on gene-edited crops as droughts and wars bite

      The European Commission is considering easing regulation on the technology. But critics say it is an untested risk being pushed by Big Ag

    • Monday, 3 October, 2022
      Nobel prizes
      Swedish geneticist wins Nobel prize for decoding DNA of human ancestors

      Svante Pääbo’s sequencing of the Neanderthal’s genome boosts understanding of evolution

    • Tuesday, 16 August, 2022
      Scientists vow to bring Tasmanian tiger back from extinction

      US biotech behind project to recreate woolly mammoth turns its attention to thylacine

    • Sunday, 14 August, 2022
      Biotech
      Cambridge start-up aims to rewrite the code of life

      Constructive Bio plans to reprogramme microbes to make new materials from drugs to biodegradable plastics

    • Thursday, 28 July, 2022
      Medical science
      First genetic treatment for inherited heart disease receives £30mn funding

      Injectable cure for congenital cardiomyopathies could be available within a few years, says UK charity

    • Tuesday, 24 May, 2022
      Agritech
      Plant scientists welcome UK bill to deregulate crop engineering

      Campaigners warn against loosening of gene editing rules made possible by Brexit

    • Sunday, 13 March, 2022
      ExplainerCoronavirus pandemic
      How can genomic sequencing spot the next coronavirus variant?

      Discovery of new strain that combines elements of Delta and Omicron shows importance of surveillance

    • Monday, 7 March, 2022
      Coronavirus treatment
      Scientists identify genetic factors behind severe Covid

      Sixteen genes that predispose people to critical illness pinpointed in world’s largest study of its kind

    • Wednesday, 9 February, 2022
      ReviewNon-Fiction
      Control by Adam Rutherford — the past and present dangers of eugenics

      The broadcaster and geneticist takes a clear-sighted look at a troublesome ideology

    • Wednesday, 12 January, 2022
      Coronavirus pandemic
      BioNTech and AI start-up develop tool to predict high-risk coronavirus variants

      Hopes early warning system will give policymakers and vaccine producers more time to address health risks

    • Tuesday, 7 December, 2021
      Coronavirus pandemic
      Omicron variant offshoot could make global tracking more difficult

      PCR tests will detect infections but uneven access to genomic surveillance hampers efforts to trace spread

    • Friday, 3 December, 2021
      News in-depthCoronavirus pandemic
      Omicron variant highlights uneven genomic sequencing worldwide

      Large parts of the world lack tools needed to identify new coronavirus strains

    • Monday, 15 November, 2021
      Anjana Ahuja
      Couples who share beds but not Covid may hold clue to ‘invincibility’

      Analysing the genes of those who appear to be naturally resistant could lead to antiviral treatments

    • Wednesday, 10 November, 2021
      Scientists use genomic sequencing to pinpoint cause of rare diseases

      Groundbreaking research will improve care of patients with undiagnosed conditions and cut costs

    • Monday, 8 November, 2021
      Healthcare
      Pandemic puts Oxford Nanopore ‘on the map’

      University spinout’s portable DNA sequencer has proved invaluable in tracking the global spread of coronavirus

    Previous page You are on page 1 Next page

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Banks in turmoil
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • FTfm
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In